u/bastian_ekstrom

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

heart rate is the thing people report watching

Have you held a step for longer than the four-week minimum at any point?

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

discontinuation rate is a result, not a footnote

the boards keep comparing it to injectables at matched doses, which is meaningless

dose response is not linear and nobody should assume it is

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

Are you comparing yourself with the trial mean or with the people who post the most?

Right — Homopeptide answered a handling question with actual storage conditions rather than a generic line, which is the standard.

Disagreeing with this bit: handling for one compound does not transfer to another by default.

glucagon agonism sounds paradoxical until you read the energy expenditure work

GIP is the arm people argue about because the biology is genuinely unsettled

This is the concept everything else on this board is downstream of.

week 10 is early to draw any conclusion at all

Kept a log specifically because there is so little published.

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

Confirmation took forty minutes on a busy evening and I had already written half an angry message. Deleted it.

Annotated the fortnight I changed training. Without that note the numbers around it would look like a mystery.

What was the comparator?

Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.

GIP is the arm people argue about because the biology is genuinely unsettled

Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed I had made a mistake. Month two it moved.

a logger costs less than a vial and answers the question permanently

cesar_teixeira is right that the pack failing is not the material failing. Two separate claims.

Yes — gas is the network’s, not the supplier’s, and conflating them produces a lot of unfair complaints.

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

the confidence interval is the finding, the point estimate is the headline

wait for phase 3 before you argue about rankings

Escrow is not standard in this space. Wanting it is reasonable; expecting it as default is not.

Did you come to this from sema, and if so how long was the gap?

log what you did, not what you meant to do

Small fix — that is a reconstructed entry rather than a contemporaneous one, and the post presents it as the latter.

Rate quotes expire because the underlying rate moves. A short expiry is ordinary; urgency about your decision is a separate signal and should be read separately.

Are the missed weeks in there as blanks or dropped entirely?

Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.

Held 7.5 for five months. Everyone kept asking when I was going to 10. The answer was never, because 7.5 was working.

the nausea profile is genuinely gentler than people expect coming from sema

not approved anywhere, which is the single most important fact in this board

the column you will wish you had is sleep

Agreed — and the payoff genuinely arrives in month six, not week two.

Asked a question here that I thought was stupid and got three papers back. Best thread I have been in on this site.

the central appetite effect is doing more work than the gut effect

the same name covers several different molecules in this space